Table 2 Risk factors for the composite outcome
From: Outcomes of COVID-19 and risk factors in patients with cancer
Composite outcome | Unadjusted analysis | Adjusted analysis | ||||
|---|---|---|---|---|---|---|
OR with 95% CI | P | OR with 95% CI | P | |||
Age, years | – | 1.03 (1.02–1.04) | <0.001 | 1.02 (1.01–1.03) | 0.006 | |
Sex | Female | 69 out of 523 (13%) | ref. | ref. | ||
Male | 91 out of 730 (13%) | 0.94 (0.67–1.31) | 0.704 | 0.79 (0.53–1.12) | 0.25 | |
Smoking | No | 120 out of 1,041 (12%) | ref. | ref. | ||
Yes | 36 out of 186 (19%) | 1.84 (1.22–2.78) | 0.004 | 1.78 (1.09–2.88) | 0.021 | |
Comorbidities | None | 86 out of 847 (10%) | ref. | ref. | ||
One | 40 out of 249 (16%) | 1.69 (1.13–2.54) | 0.011 | 1.35 (0.86–2.11) | 0.189 | |
Two or more | 31 out of 145 (21%) | 2.41 (1.53–3.79) | <0.001 | 1.89 (1.13–3.15) | 0.016 | |
Cancer type | Solid | 122 out of 960 (13%) | ref. | ref. | ||
Hematolymphoid | 38 out of 293 (13%) | 1.02 (0.69–1.51) | 0.907 | 1.60 (0.99–2.57) | 0.052 | |
Treatment intent | Curative | 70 out of 900 (8%) | ref. | ref. | ||
Palliative | 88 out of 344 (26%) | 4.08 (2.89–5.75) | <0.001 | 3.50 (2.42–5.05) | <0.001 | |
On active SACT within 30 d before COVID-19 diagnosis | No | 99 out of 812 (12%) | ref. | ref. | ||
Yes | 61 out of 439 (14%) | 1.16 (0.83–1.64) | 0.390 | 1.11 (0.74–1.67) | 0.628 | |
